Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial): This study showed that tirzepatide can lead to significant weight loss during active treatment compared with placebo
The strongest route-specific work uses oral delivery into inflamed gut tissue, not SubQ delivery for human skin. The evidence does not transfer cleanly across dose, route, or formulation
Verify that providers are licensed in your state and in good standing
Whatever it may be, minimizing added sugars and artificial ingredients is always a good idea, so be sure to look at the food label when choosing. Even if I dont continue to eat ice cream every day, I will always enjoy it as a special treat
Sci Rep (2018) 8:74
Semaglutide belongs to a broader class of medications known as GLP-1 receptor agonists, which are used to treat obesity and type 2 diabetes. Semaglutides act like the glucagon-like peptide-1 (GLP-1) hormone our bodies make, which is released from our gut after we eat, explains Jessica Duncan, MD, DABOM, DABA, chief medical officer at Ivim Health